Learn more about the products and register for product demonstrations.

Access the Demo
PathAI logo

Introducing IHC Explore™

Empowering cancer drug developers and clinical researchers with AI-powered insights.1

IHC Explore: AI-Powered Biomarker Quantification

IHC Explore addresses the challenges of Immunohistochemistry (IHC) based scoring, providing AI-powered IHC assay quantification at tissue, cellular, and subcellular resolution. This tool enhances biomarker discovery and quantification, informing treatment strategies and patient stratification with unmatched precision.

Extract key histopathological features from Immunohistochemistry (IHC) slide images and transform IHC whole-slide images into quantitative insights for next-generation biomarker development.

IHC Explore features

Characterize IHC stains and biomarker expression with spatially-contextualized, single-cell resolution

  • Accelerate and enhance the development of AI-enabled biomarkers for novel IHC assays​
  • Rapid deployment at scale enables continuous quantification of biomarkers
  • Deep quantitative measurements of cell types, stain intensity, and completeness
  • Identify spatial patterns of stain and expression heterogeneity that are not encapsulated by categorical scores
  • Unveil distinct sub-populations that drive novel biomarker discovery and standardization for scoring strategies
image of 4 cell views

Learn More

Connect with our business development team to learn more about IHC Explore.
Contact Us

IHC Explore is for research use only. Not for use in diagnostic procedures.